MITUXA RESEARCH · GLOBAL MODEL PORTFOLIO

MITUXA Portfolio

Ten candidates across regions and industries. We allocate capital only when both the business and its price meet our criteria.

Model capital
€50,000
Target allocation per position
€5,000
Holdings at launch
0
Model cash at launch
€50,000

How the portfolio works

The investment horizon is three to five years, with a quarterly review and no requirement to trade. This is separate from One Quarter, MITUXA’s quarterly momentum experiment.

Each candidate starts with a €5,000 cash allocation. Entry requires an intact fundamental thesis and a price that offers a margin of safety. At full target weights, the candidate list would allocate 40% to North America, 30% to Europe and 30% to Asia-Pacific by company location, not by revenue. We also look for shared exposure to commodities, industrial demand and currencies.

Once performance reporting starts, returns will be measured in euros, including dividends and currency effects, against the MSCI ACWI Net Return index in EUR from the same start date. We will disclose the date, model execution price, share count and any currency conversion for each entry. Reference closes are not executions.

Candidate list

These are research candidates, not holdings. Seven companies still await a valuation review.

Research pending

Visa V

United States · Payments

Cross-border payments and regulatory pressure.

Research pending

Costco COST

United States · Essential retail

Membership renewals and the growth already priced in.

Research pending

Waste Connections WCN

Canada / United States · Waste services

Organic growth, cash conversion and acquisition returns.

Research pending

Canadian Natural Resources CNQ

Canada · Oil and gas production

Free cash flow at lower oil prices and capital discipline.

Research pending

ASML ASML

Netherlands · Semiconductor equipment

Orders, customer concentration and export restrictions.

Entry candidate

bioMérieux BIM

France · Diagnostics

Test volumes per installed instrument and margin recovery.

Watch

ANDRITZ ANDR

Austria · Industrial engineering

Backlog conversion, project margins and working capital.

Watch

KDDI 9433

Japan · Telecoms

Cash after network investment and the yen exposure.

Research pending

Tokyo Gas 9531

Japan · Gas utility

LNG and currency sensitivity, cost pass-through and investment returns.

Research pending

BHP BHP

Australia · Mining

Copper and iron ore economics under normalised commodity prices.

First valuation reviews

Reference closes: 17 November 2026. Fair values, entry ranges and downside cases are MITUXA estimates, not consensus targets. An entry range triggers a fresh check, not an automatic transaction.

bioMérieux

Reference close
€90.65
Central fair value
€110
Entry range
€85–93

Reported: Third-quarter organic sales grew 8%, versus 2.7% over the first nine months. First-half adjusted diluted EPS was €1.99, down 17% as reported. A sales rebound is not yet proof of an earnings rebound.

Valuation: €4.80 in normalised adjusted earnings per share × 23. Downside scenario: €4.20 × 19, or about €80.

MITUXA view: The reference close was within our entry zone. Before booking a model position, check the executable price and confirm that instrument placements translate into recurring test volumes, margins and cash.

ANDRITZ

Reference close
€81.00
Central fair value
€88
Entry range
€72–76

Reported: Third-quarter sales grew 9.2%, the comparable EBITA margin was 9.0%, and backlog reached €12.73 billion. Quarterly order intake was broadly flat: hydropower strength offset weakness in pulp and paper.

Valuation: €5.50 in normalised earnings per share × 16. Downside scenario: €4.80 × 14, or about €67.

MITUXA view: The discount to fair value is too thin for a project business. Watch whether the backlog converts into cash without margin erosion or a persistent increase in working capital.

KDDI

Reference close
¥2,954.50
Central fair value
¥3,050
Entry range
¥2,550–2,650

Reported: In the six months to September, sales grew 4.7%, operating profit rose 0.8% as reported and 13.9% on an adjusted basis. Basic EPS was ¥96.83 reported and ¥103.97 adjusted.

Valuation: ¥210 in normalised earnings per share × 14.5, rounded. The EPS assumption approximates twice the latest adjusted half-year EPS; it is not company guidance. Downside scenario: ¥190 × 12.5, or ¥2,375.

MITUXA view: Wait for a wider discount. Check the adjustments and free cash flow after network investment. The share is valued in yen, but portfolio returns will be measured in euros.

Transaction record

No trades have been recorded. All ten allocations remain in model cash.

Independent research for information and education. This model does not represent client assets and is not personalised investment advice.